Bivalirudin not superior to heparin in STEMI patients undergoing PCI: Circulation

Sweden: A recent study showed no benefit of Bivalirudin versus heparin in patients with STEMI undergoing primary percutaneous coronary intervention (PCI) with radial access and currently recommended...

Related Keywords

Sweden ,Uppsala ,Uppsala Lan ,Swedish ,Stefan James ,Uppsala University ,Department Of Medical Sciences ,Development Of Evidence ,Bivalirudin Versus Heparin ,Modern Antiplatelet Therapy ,Swedish Web System ,Evidence Based Care ,Heart Disease Evaluated According ,Recommended Therapies Registry ,Medical Sciences ,Elevation Myocardial Infarction ,Bivalirudin ,Heparin ,Pci ,Istemi ,St Segment Elevation ,Myocardial Infarction ,Mortality ,Bleeding ,Cardiovascular Disease ,Ocvd ,Percutaneous Coronary Intervention ,Anticoagulants ,